“Anti-TNF Treatment In Refractory Sarcoidosis; Therapeutic Impacts Of Adalimumab And Infliximab”. The Review of Diabetic Studies (June 25, 2025): 113–123. Accessed October 8, 2025. https://www.diabeticstudies.org/index.php/RDS/article/view/656.